Functional interactions of Raf and MEK with jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic ras signaling pathway

被引:30
作者
Adler, V
Qu, YX
Smith, SJ
Izotova, L
Pestka, S
Kung, HF
Lin, M
Friedman, FK
Chie, L
Chung, D
Boutjdir, M
Pincus, MR
机构
[1] New York Harbor VA Med Ctr, Dept Pathol & Lab Med 113, Brooklyn, NY 11209 USA
[2] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[3] QRNA Corp, New York, NY 10032 USA
[4] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA
[5] Univ Med & Dent New Jersey, Dept Microbiol & Human Genet, Robert Wood Johnson Med Ctr, Piscataway, NJ 08854 USA
[6] NCI, Lab Expt & Computat Biol, Bethesda, MD 20892 USA
[7] Chinese Univ Hong Kong, Dept Virol, Hong Kong, Hong Kong, Peoples R China
[8] Long Isl Univ, Dept Chem & Biol, Brooklyn, NY 11201 USA
[9] Canc Inst New Jersey, New Brunswick, NJ 08901 USA
关键词
D O I
10.1021/bi050619j
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In previous studies we have found that oncogenic (Val 12)-ras-p21 induces Xenopus laevis oocyte maturation that is selectively blocked by two ras-p21 peptides, 35-47, also called PNC-7, that blocks its interaction with raf, and 96-110, also called PNC-2, that blocks its interaction with jun-N-terminal kinase (INK). Each peptide blocks activation of both JNK and MAP kinase (MAPK or ERK) suggesting interaction between the raf-MEK-ERK and JNK-jun pathways. We further found that dominant negative raf blocks JNK induction of oocyte maturation, again suggesting cross-talk between pathways. In this study, we have undertaken to determine where these points of cross-talk occur. First, we have immunoprecipitated injected Val 12-Ha-ras-p21 from oocytes and found that a complex forms between ras-p21 raf, MEK, MAPK, and JNK. Co-injection of either peptide, but not a control peptide, causes diminished binding of ras-p21, raf, and JNK. Thus, one site of interaction is cooperative binding of Val 12-ras-p21 to raf and JNK. Second, we have injected JNK, c-raf, and MEK into oocytes alone and in the presence of raf and MEK inhibitors and found that JNK activation is independent of the raf-MEK-MAPK pathway but that activated JNK activates raf, allowing for activation of ERK. Furthermore, we have found that constitutively activated MEK activates JNK. We have corroborated these findings in studies with isolated protein components from a human astrocyte (U-251) cell line; that is, JNK phosphorylates raf but not the reverse; MEK phosphorylates JNK but not the reverse. We further have found that JNK does not phosphorylate MAPK and that MAPK does not phosphorylate JNK. The stress-inducing agent, anisomycin, causes activation of JNK, raf, MEK, and ERK in this cell line; activation of JNK is not inhibitable by the MEK inhibitor, U0126, while activation of raf, MEK, and ERK are blocked by this agent. These results suggest that activated JNK can, in turn, activate not only jun but also raf that, in turn, activates MEK that can then cross-activate JNK in a positive feedback loop.
引用
收藏
页码:10784 / 10795
页数:12
相关论文
共 33 条
[1]  
Adler V, 2004, ANN CLIN LAB SCI, V34, P35
[2]   COMPLEXES OF P21(RAS) WITH JUN N-TERMINAL KINASE AND JUN PROTEINS [J].
ADLER, V ;
PINCUS, MR ;
BRANDTRAUF, PW ;
RONAI, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10585-10589
[3]   Activation of c-Jun-NH2-kinase by UV irradiation is dependent on p21(ras) [J].
Adler, V ;
Pincus, MR ;
Polotskaya, A ;
Montano, X ;
Friedman, FK ;
Ronai, Z .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (38) :23304-23309
[4]   Regulation of JNK signaling by GSTp [J].
Adler, V ;
Yin, ZM ;
Fuchs, SY ;
Benezra, M ;
Rosario, L ;
Tew, KD ;
Pincus, MR ;
Sardana, M ;
Henderson, CJ ;
Wolf, CR ;
Davis, RJ ;
Ronai, Z .
EMBO JOURNAL, 1999, 18 (05) :1321-1334
[5]   Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agents [J].
Amar, S ;
Glozman, A ;
Chung, D ;
Adler, V ;
Ronai, Z ;
Friedman, FK ;
Robinson, R ;
BrandtRauf, P ;
Yamaizumi, Z ;
Pincus, MR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 41 (01) :79-85
[6]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[7]  
BAUM EZ, 1990, ONCOGENE, V5, P763
[8]   RAS PROTEINS CAN INDUCE MEIOSIS IN XENOPUS OOCYTES [J].
BIRCHMEIER, C ;
BROEK, D ;
WIGLER, M .
CELL, 1985, 43 (03) :615-621
[9]   An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21 [J].
Chie, L ;
Adler, V ;
Friedman, FK ;
Chung, D ;
Pincus, MR .
PROTEIN JOURNAL, 2004, 23 (03) :235-238
[10]   Identification of the site of inhibition of mitogenic signaling by oncogenic ras-p21 by a ras effector peptide [J].
Chie, L ;
Friedman, FK ;
Kung, HF ;
Lin, MCM ;
Chung, D ;
Pincus, MR .
JOURNAL OF PROTEIN CHEMISTRY, 2002, 21 (05) :367-370